[ 3 ] Oelschlaegel U, Besson I, Arnoulet C, et al. A standardized flow cytometric method for screening paroxysmal nocturnal hemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes[J]. Clin Lab Haematol, 2001, 23(2): 81-90.
[ 5 ] Pilar MH, Marta MA, Julia A, et al. Comparative analysis of different flow cytometry based immuophenotypic methods for the analysis of CD55 and CD59 expression on major peripheral blood cell subsets[J]. Cytometry, 2002, 50(3): 191-201 .
[6]
[ 6 ] Okuda K, Kanamaru, AUeda E, et al. Membrane expression of decay-accelerating factor on neutrophil from normal individuals and patients with paroxysmal nocturnal hemoglobinuria[J]. Blood, 1990, 75(5): 1186-1191.
Sugimori C, Chuhjo T, Feng XM, et al. Minor population of CD55- CD59- blood cells predicts response to immunosuppessive therapy and prognosis in patients with aplastic anemia[J]. Blood, 2006, 107(4): 1308-1314.
[14]
Young NS. The problem of clonality in aplastic anemia: Dr. Dameshek’s riddle, restated[J]. Blood, 1992, 79(9): 1385-1392.
Maciejewski JP, Rivera C, Kook H, et al. Relationship between bone marrow failure syndromes and the presence of glycosylphosphatidylinositol anchored protein-deficient clones[J]. Br J Haematol, 2001, 115(4): 1015-1022.
[17]
Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cell in patients with bone marrow failure syndromes[J]. Ann Intern Med, 1999, 131(6): 401-408.
